Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Frontiers in Pharmacology|January 24, 2022
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug MonitoringValeria Avataneo, Elvira Fanelli, Amedeo De Nicolò, et al.
Journal of Medical Virology|July 8, 2020
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancyStefano Cosma, Fulvio Borella, Andrea Carosso, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 25, 2017
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samplesAmedeo De Nicolò, Valeria Avataneo, Franco Rabbia, et al.
American Journal of Obstetrics and Gynecology|October 11, 2020
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patientsStefano Cosma, Andrea R Carosso, Jessica Cusato, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 27, 2013
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spotsLorena Baietto, Antonio D'Avolio, Alessandra Ariaudo, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Targeting TOP2A in Ovarian Cancer: Biological and Clinical ImplicationsFulvio Borella, Stefano Fucina, Ylenia Seminara, et al.
British Journal of Clinical Pharmacology|July 5, 2018
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherenceValeria Avataneo, Amedeo De Nicolò, Franco Rabbia, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 8, 2016
UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patientsAmedeo De Nicolò, Valeria Avataneo, Franco Rabbia, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2020
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus diseaseValeria Avataneo, Amedeo de Nicolò, Jessica Cusato, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2010
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluationAntonio D'Avolio, Marco Simiele, Marco Siccardi, et al.
Pageof 16